Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer

Part of paid clinical trials in Los Angeles, California.

Sponsor
Jonsson Comprehensive Cancer Center
Study ID
NCT04742608
Status
Recruiting

Conditions

  • Thyroid Gland Carcinoma
  • Thyroid Gland Nodule

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biospecimen Collection — PROCEDURE
    Undergo collection of blood and tissue samples
  • Electronic Health Record Review — OTHER
    Medical charts are reviewed

Study Details

This study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less invasive to the patient. Analyzing blood and tissues samples may also help researchers to differentiate non-cancerous tumors from thyroid cancer and detect high-risk mutations to guide treatment.

Key Dates

Start date
Feb 21, 2020
Status verified
Mar 2026
Primary completion
Jun 9, 2025
Completion
Feb 1, 2027

Study Design

Enrollment
250 participants (estimated)

Arms

  • Arm: Ancillary-correlative (biospecimen collection)
    Patients undergo collection of blood samples on the day of surgery following anesthesia but prior to incision and at the first routine blood test following surgery. Patients who undergo remnant ablation after total thyroidectomy with radioactive iodine have an additional blood sample collected. Patients also undergo collection of tissue samples following surgical resection of thyroid nodule or thyroid cancer. Patients' medical records are also reviewed.

Primary Outcome Measure

Sensitivity of molecular profile of thyroid-derived extracellular vesicles [ Time Frame: Up to 3 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
UCLA / Jonsson Comprehensive Cancer CenterLos AngelesCalifornia90095
James Wu
303-518-3186
James Wu (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

Related Studies